References
- Bradley D. D., Wingard J., Petitti D. B., Krauss R. M., Ramcharan S. Serum high-density-lipoprotein cholesterol in women using oral contraceptives, estragens and progestins. New Engl J Med 1978; 299: 17–20
- Burstein M., Samaille J. Sur un dosage rapide de cholésterol lié au alpha- et au béta-lipoprotéins du sérum. Clin Chim Acta 1955; 5: 609
- Carlson L. A., Rössner S. A methodological study of an intravenous fat-tolerance test with IntralipidR emulsion. Scand J Clin Lab Invest 1972; 29: 271–280
- Curry M. C., Alaupovic P., Suenram C. A. Determination of apolipoprotein A and its constitutive A-I and A-II polypeptides by separate electroimmunoassays. Clin Chem 1976; 22: 315–322
- Diaz S., Parez M., Robertson P. N., Croxatto H. B. A 3-year clinical trial with levonorgestrel silastic implants. Contraception 1979; 19: 557–574
- Havel R. J., Eder H. A., Bragdon J. H. The determination and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955; 34: 1345–1353
- Hirsch J., Goldrick R. B. Serial studies on the metabolism of human adipose tissue. I. Lipogenesis and free fatty-acid uptake and release in small aspirated samples of subcutaneous fat. J Clin Invest 1964; 43: 1776–1792
- Ikkos D., Luft R. On the intravenous glucose-tolerance test. Acta Endocrinol (Kbh) 1957; 25: 312–334
- Kinnunen P. K. J., Virtanen I. Mode of action of the hepatic endothelial lipase: Recycling endocytosis via coated pits. Atherosclerosis V, A. M. Gotto, Jr., L. C. Smith, B. Allen. Springer Verlag, New York 1980; 383–386
- Kuusi T., Saarinen P., Nikkilä E. A. Evidence for the role of hepatic endothelial lipase in the metabolism of plasma high density lipoprotein2 in man. Atherosclerosis 1981; 36: 589–593
- Laurell C. B. Electroimmunoassay. Scand J Clin Lab Invest 1972; 29(suppl. 124)21–37
- Lithell H., Boberg J. A method of determining lipoprotein-lipase activity in human adipose tissue. Scand J Clin Lab Invest 1977; 37: 551–561
- Luskey K. L., Brown M. S., Goldstein J. L. Stimulation of the synthesis of very-low-density lipoproteins in rooster liver by estradiol. J Biol Chem 1974; 249: 5939–5947
- Rush R. L., Leon L., Turell J. Automated simultaneous cholesterol and triglyceride determination on the Auto Analyzer II instrument. Advances in Automated Analysis. Thurman Associates. 1972; vol. 1: 503–507
- Sjöström L., Björntorp P., Vrańa J. Microscopic fat-cell-size measurements of frozen-cut adipose tissue in comparison with automatic determinations of osmium-fixed fat cells. J Lipid Res 1971; 12: 521–530
- Weiner E., Johansson E. D. B. Plasma levels of d-norgestrel, estradiol and progesterone during treatment with silastic implants containing d-norgestrel. Contraception 1976; 14: 81–92
- Vessby B., Boberg J., Gustafsson I.-B-., Karlström B., Lithell H., Östlund-Lindqvist A.-M. Reduction of high-density-lipoprotein cholesterol and apolipoprotein A-I concentrations by a lipid-lowering diet. Atherosclerosis 1980; 35: 21–27
- Åhrén T., Lithell H., Victor A., Vessby B., Johansson E. D. B. Comparison of the metabolic effects of two hormonal contraceptive methods: An oral formulation and a vaginal ring. II. Serum lipoproteins and apolipoproteins. Contraception 1981; 24: 451–468
- Åhrén T., Lithell H., Victor A., Vessby B., Johansson E. D. B. Serum lipoprotein and apolipoprotein changes during treatment with a contraceptive vaginal ring containing levonorgestrel and estradiol. Acta Obst Gynecol Scand, in press